LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 32

Search options

  1. Article ; Online: Considering pharmacoequity when deprescribing potentially inappropriate medications.

    Sloan, Caroline E / Hung, Anna

    Journal of the American Geriatrics Society

    2023  Volume 71, Issue 6, Page(s) 1698–1700

    MeSH term(s) Humans ; Potentially Inappropriate Medication List ; Deprescriptions ; Inappropriate Prescribing/prevention & control ; Polypharmacy
    Language English
    Publishing date 2023-04-10
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Comment
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.18366
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Patients want to talk about their out-of-pocket costs-Can real-time benefit tools help?

    Sloan, Caroline E / Ubel, Peter A

    Journal of the American Geriatrics Society

    2023  Volume 71, Issue 5, Page(s) 1365–1368

    MeSH term(s) Humans ; Health Expenditures
    Language English
    Publishing date 2023-03-20
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.18342
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Effectiveness and safety of drugs for obesity.

    Henderson, Kristina / Lewis / Sloan, Caroline E / Bessesen, Daniel H / Arterburn, David

    BMJ (Clinical research ed.)

    2024  Volume 384, Page(s) e072686

    Abstract: Recent publicity around the use of new antiobesity medications (AOMs) has focused the attention of patients and healthcare providers on the role of pharmacotherapy in the treatment of obesity. Newer drug treatments have shown greater efficacy and safety ... ...

    Abstract Recent publicity around the use of new antiobesity medications (AOMs) has focused the attention of patients and healthcare providers on the role of pharmacotherapy in the treatment of obesity. Newer drug treatments have shown greater efficacy and safety compared with older drug treatments, yet access to these drug treatments is limited by providers' discomfort in prescribing, bias, and stigma around obesity, as well as by the lack of insurance coverage. Now more than ever, healthcare providers must be able to discuss the risks and benefits of the full range of antiobesity medications available to patients, and to incorporate both guideline based advice and emerging real world clinical evidence into daily clinical practice. The tremendous variability in response to antiobesity medications means that clinicians need to use a flexible approach that takes advantage of specific features of the antiobesity medication selected to provide the best option for individual patients. Future research is needed on how best to use available drug treatments in real world practice settings, the potential role of combination therapies, and the cost effectiveness of antiobesity medications. Several new drug treatments are being evaluated in ongoing clinical trials, suggesting that the future for pharmacotherapy of obesity is bright.
    MeSH term(s) Humans ; Obesity/drug therapy ; Anti-Obesity Agents/adverse effects
    Chemical Substances Anti-Obesity Agents
    Language English
    Publishing date 2024-03-25
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj-2022-072686
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Real-world use of a medication out-of-pocket cost estimator in primary care one year after Medicare regulation.

    Sloan, Caroline E / Morton-Oswald, Sarah / Smith, Valerie A / Sinaiko, Anna D / Bowling, C Barrett / An, Jaejin / Maciejewski, Matthew L

    Journal of the American Geriatrics Society

    2024  

    Language English
    Publishing date 2024-01-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.18774
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The 7 Habits of Highly Effective Cost-of-Care Conversations.

    Sloan, Caroline E / Ubel, Peter A

    Annals of internal medicine

    2019  Volume 170, Issue 9_Suppl, Page(s) S33–S35

    MeSH term(s) Communication ; Cost of Illness ; Health Expenditures ; Humans ; Physician-Patient Relations ; Primary Health Care/economics ; Primary Health Care/organization & administration ; Prognosis ; United States
    Language English
    Publishing date 2019-04-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/M19-0537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.

    Hung, Anna / Wilson, Lauren / Smith, Valerie A / Pavon, Juliessa M / Sloan, Caroline E / Hastings, Susan N / Farley, Joel / Maciejewski, Matthew L

    JAMA health forum

    2024  Volume 5, Issue 5, Page(s) e240807

    Abstract: Importance: Comprehensive medication reviews (CMRs) are offered to qualifying US Medicare beneficiaries annually to optimize medication regimens and therapeutic outcomes. In 2016, Medicare adopted CMR completion as a Star Rating quality measure to ... ...

    Abstract Importance: Comprehensive medication reviews (CMRs) are offered to qualifying US Medicare beneficiaries annually to optimize medication regimens and therapeutic outcomes. In 2016, Medicare adopted CMR completion as a Star Rating quality measure to encourage the use of CMRs.
    Objective: To examine trends in CMR completion rates before and after 2016 and whether racial, ethnic, and socioeconomic disparities in CMR completion changed.
    Design, setting, and participants: This observational study using interrupted time-series analysis examined 2013 to 2020 annual cohorts of community-dwelling Medicare beneficiaries aged 66 years and older eligible for a CMR as determined by Part D plans and by objective minimum eligibility criteria. Data analysis was conducted from September 2022 to February 2024.
    Exposure: Adoption of CMR completion as a Star Rating quality measure in 2016.
    Main outcome and measures: CMR completion modeled via generalized estimating equations.
    Results: The study included a total of 561 950 eligible beneficiaries, with 253 561 in the 2013 to 2015 cohort (median [IQR] age, 75.8 [70.7-82.1] years; 90 778 male [35.8%]; 6795 Asian [2.7%]; 24 425 Black [9.6%]; 7674 Hispanic [3.0%]; 208 621 White [82.3%]) and 308 389 in the 2016 to 2020 cohort (median [IQR] age, 75.1 [70.4-80.9] years; 126 730 male [41.1%]; 8922 Asian [2.9%]; 27 915 Black [9.1%]; 7635 Hispanic [2.5%]; 252 781 White [82.0%]). The unadjusted CMR completion rate increased from 10.2% (7379 of 72 225 individuals) in 2013 to 15.6% (14 185 of 90 847 individuals) in 2015 and increased further to 35.8% (18 376 of 51 386 individuals) in 2020, in part because the population deemed by Part D plans to be MTM-eligible decreased by nearly half after 2015 (90 487 individuals in 2015 to 51 386 individuals in 2020). Among a simulated cohort based on Medicare minimum eligibility thresholds, the unadjusted CMR completion rate increased but to a lesser extent, from 4.4% in 2013 to 12.6% in 2020. Compared with White beneficiaries, Asian and Hispanic beneficiaries experienced greater increases in likelihood of CMR completion after 2016 but remained less likely to complete a CMR. Dual-Medicaid enrollees also experienced greater increases in likelihood of CMR completion as compared with those without either designation, but still remained less likely to complete CMR.
    Conclusion and relevance: This study found that adoption of CMR completion as a Star Rating quality measure was associated with higher CMR completion rates. The increase in CMR completion rates was achieved partly because Part D plans used stricter eligibility criteria to define eligible patients. Reductions in disparities for eligible Asian, Hispanic, and dual-Medicaid enrollees were seen, but not eliminated. These findings suggest that quality measures can inform plan behavior and could be used to help address disparities.
    MeSH term(s) Humans ; United States ; Aged ; Male ; Female ; Aged, 80 and over ; Healthcare Disparities/statistics & numerical data ; Healthcare Disparities/ethnology ; Medicare/statistics & numerical data ; Interrupted Time Series Analysis ; Medicare Part D/statistics & numerical data ; Ethnicity/statistics & numerical data
    Language English
    Publishing date 2024-05-03
    Publishing country United States
    Document type Journal Article ; Observational Study ; Research Support, N.I.H., Extramural
    ISSN 2689-0186
    ISSN (online) 2689-0186
    DOI 10.1001/jamahealthforum.2024.0807
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Online Crowdfunding Campaigns for Diabetes-Related Expenses.

    Sloan, Caroline E / Campagna, Ada / Tu, Karissa / Doerstling, Steven / Davis, J Kelly / Ubel, Peter A

    Annals of internal medicine

    2023  Volume 176, Issue 7, Page(s) 1012–1014

    MeSH term(s) Humans ; Healthcare Financing ; Diabetes Mellitus/therapy
    Language English
    Publishing date 2023-06-13
    Publishing country United States
    Document type Letter
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/M23-0540
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.

    Amin, Krunal / Bethel, Garrett / Jackson, Larry R / Essien, Utibe R / Sloan, Caroline E

    Current atherosclerosis reports

    2023  Volume 25, Issue 12, Page(s) 1113–1127

    Abstract: Purpose of review: Pharmacoequity refers to the goal of ensuring that all patients have access to high-quality medications, regardless of their race, ethnicity, gender, or other characteristics. The goal of this article is to review current evidence on ... ...

    Abstract Purpose of review: Pharmacoequity refers to the goal of ensuring that all patients have access to high-quality medications, regardless of their race, ethnicity, gender, or other characteristics. The goal of this article is to review current evidence on disparities in access to cardiovascular drug therapies across sociodemographic subgroups, with a focus on heart failure, atrial fibrillation, and dyslipidemia.
    Recent findings: Considerable and consistent disparities to life-prolonging heart failure, atrial fibrillation, and dyslipidemia medications exist in clinical trial representation, access to specialist care, prescription of guideline-based therapy, drug affordability, and pharmacy accessibility across racial, ethnic, gender, and other sociodemographic subgroups. Researchers, health systems, and policy makers can take steps to improve pharmacoequity by diversifying clinical trial enrollment, increasing access to inpatient and outpatient cardiology care, nudging clinicians to increase prescription of guideline-directed medical therapy, and pursuing system-level reforms to improve drug access and affordability.
    MeSH term(s) Humans ; Atrial Fibrillation/drug therapy ; Heart Failure/drug therapy ; Ethnicity ; Dyslipidemias/drug therapy ; Dyslipidemias/epidemiology ; Health Inequities
    Language English
    Publishing date 2023-12-18
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057369-8
    ISSN 1534-6242 ; 1523-3804
    ISSN (online) 1534-6242
    ISSN 1523-3804
    DOI 10.1007/s11883-023-01180-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling.

    Sloan, Caroline E / Millo, Lorena / Gutterman, Sophia / Ubel, Peter A

    JAMA network open

    2021  Volume 4, Issue 11, Page(s) e2133188

    Abstract: Importance: One-third of US residents have trouble paying their medical bills. They often turn to their physicians for help navigating health costs and insurance coverage.: Objective: To determine whether physicians can accurately estimate out-of- ... ...

    Abstract Importance: One-third of US residents have trouble paying their medical bills. They often turn to their physicians for help navigating health costs and insurance coverage.
    Objective: To determine whether physicians can accurately estimate out-of-pocket expenses when they are given all of the necessary information about a drug's price and a patient's insurance plan.
    Design, setting, and participants: This national mail-in survey used a random sample of US physicians. The survey was sent to 900 outpatient physicians (300 each of primary care, gastroenterology, and rheumatology). Physicians were excluded if they were in training, worked primarily for the Veterans Administration or Indian Health Service, were retired, or reported 0% outpatient clinical effort. Analyses were performed from July to December 2020.
    Main outcomes and measures: In a hypothetical vignette, a patient was prescribed a new drug costing $1000/month without insurance. A summary of her private insurance information was provided, including the plan's deductible, coinsurance rates, copays, and out-of-pocket maximum. Physicians were asked to estimate the drug's out-of-pocket cost at 4 time points between January and December, using the plan's 4 types of cost-sharing: (1) deductibles, (2) coinsurance, (3) copays, and (4) out-of-pocket maximums. Multivariate linear regression was used to assess differences in performance by specialty, adjusting for attitudes toward cost conversations, demographics, and clinical characteristics.
    Results: The response rate was 45% (405 of 900) and 371 respondents met inclusion criteria. Among the respondents included in this study, 59% (n = 220) identified as male, 23% (n = 84) as Asian, 3% (n = 12) as Black, 6% (n = 24) as Hispanic, and 58% (n = 216) as White; 30% (n = 112) were primary care physicians, 35% (n = 128) were gastroenterologists, and 35% (n = 131) were rheumatologists; and the mean (SD) age was 49 (10) years. Overall, 52% of physicians (n = 192) accurately estimated costs before the deductible was met, 62% (n = 228) accurately used coinsurance information, 61% (n = 224) accurately used copay information, and 57% (n = 210) accurately estimated costs once the out-of-pocket maximum was met. Only 21% (n = 78) of physicians answered all 4 questions correctly. Ability to estimate out-of-pocket costs was not associated with specialty, attitudes toward cost conversations, or clinic characteristics.
    Conclusions and relevance: This survey study found that many US physicians have difficulty estimating out-of-pocket costs, even when they have access to their patients' insurance plans. The mechanics involved in calculating real-time out-of-pocket costs are complex. These findings suggest that increased price transparency and simpler insurance cost-sharing mechanisms are needed to enable informed cost conversations at the point of prescribing.
    MeSH term(s) Attitude of Health Personnel ; Cost Sharing/economics ; Deductibles and Coinsurance/economics ; Fees and Charges/statistics & numerical data ; Female ; Health Expenditures/statistics & numerical data ; Humans ; Insurance Coverage/economics ; Male ; Patient Care Team/economics
    Language English
    Publishing date 2021-11-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ISSN 2574-3805
    ISSN (online) 2574-3805
    DOI 10.1001/jamanetworkopen.2021.33188
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Deprescribing medications: Do out-of-pocket costs have a role?

    Hung, Anna / Sloan, Caroline E / Boyd, Cynthia / Bayliss, Elizabeth A / Hastings, Susan N / Maciejewski, Matthew L

    Journal of the American Geriatrics Society

    2022  Volume 70, Issue 11, Page(s) 3334–3337

    MeSH term(s) Humans ; Deprescriptions ; Health Expenditures ; Surveys and Questionnaires ; Polypharmacy
    Language English
    Publishing date 2022-08-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.17974
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top